Skip to content

Olmesartan medoxomil

Benicar, Edarbi (olmesartan medoxomil) is a small molecule pharmaceutical. Olmesartan medoxomil was first approved as Benicar on 2002-04-25. It is used to treat diabetic nephropathies, heart failure, hypertension, and left ventricular dysfunction in the USA. It has been approved in Europe to treat hypertension. The pharmaceutical is active against type-1 angiotensin II receptor.
Trade Name Edarbi
Common Name Olmesartan medoxomil
Indication diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction
Drug Class Angiotensin II receptor antagonists
Olmesartan medoxomil
Get full access now